TBD.F - Emerald Health Therapeutics, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Emerald Health Therapeutics, Inc.

800 West Pender Street
Suite 210
Vancouver, BC V6C 1J8
Canada
800-757-3536
http://emeraldhealth.ca

SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees113

Key Executives

NameTitlePayExercisedYear Born
Dr. Avtar S. DhillonExec. ChairmanN/AN/A1961
Mr. Christopher W. WagnerConsultantN/AN/A1969
Mr. Riaz BandaliCEO & PresN/AN/A1970
Ms. Jenn HepburnCFO & Company Sec.N/AN/AN/A
Mr. Michael BiermanVP of OperationsN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis in Canada. It is also involved in developing natural health products. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Corporate Governance

Emerald Health Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.